Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Mechanical Intervention for Acute Myocardial Infarction

By  

Current Medicinal Chemistry - Cardiovascular & Hematological Agents, Vol. 3, Iss. 3, 2005-07 ,pp. : 173-179

Bentham Science Publishers

Access to resources Recommend Favorite

Impact of Platelet Glycoprotein IIb/IIIa Inhibitor Therapy on In-Hospital Outcomes and Long-Term Survival Following Percutaneous Coronary Rotational Atherectomy

By Berger Jeffrey   Slater James   Sherman Warren   Green Stephen   Sanborn Timothy   Brown David  

Journal of Thrombosis and Thrombolysis, Vol. 19, Iss. 1, 2005-02 ,pp. : 47-54

Springer Publishing Company

Access to resources Recommend Favorite

The Optimal Route of Administration of the Glycoprotein IIb/IIIa Receptor Antagonist Abciximab During Percutaneous Coronary Intervention; Intravenous Versus Intracoronary

By  

Current Cardiology Reviews, Vol. 4, Iss. 4, 2008-11 ,pp. : 293-299

Bentham Science Publishers

Access to resources Recommend Favorite

Glycoprotein IIb/IIIa receptor antagonists in acute myocardial infarction and primary coronary stenting: Not always effective

By Banai Shmuel   Medina Aharon   Keren Andre  

International Journal of Cardiovascular Interventions, Vol. 3, Iss. 4, 2000-12 ,pp. : 241-243

Informa Healthcare

Access to resources Recommend Favorite

Glycoprotein IIb/IIIa Receptor Inhibitors in Acute ST-Elevation Myocardial Infarction: Will the Combination with Thrombolytics Become Reality?

By Zeymer Uwe  

Journal of Thrombosis and Thrombolysis, Vol. 15, Iss. 2, 2003-04 ,pp. : 91-97

Springer Publishing Company

Access to resources Recommend Favorite